Medical Device Manufacturer Advant Medical Celebrates Its 25th Anniversary

Food and Healthcare Press Releases Wednesday November 21, 2018 10:32
GALWAY, Ireland--21 Nov--PRNewswire/InfoQuest

Advant is a successful medical device manufacturer with corporate offices located in Galway, Ireland. For a quarter of a century, Advant has seen significant growth and development expanding into two locations in Ireland, Mexico and Costa Rica. With over 200 employees worldwide and a highly impressive customer base, the next 25 years look equally as bright as their past.

(Logo: https://mma.prnewswire.com/media/787513/Advant_Medical_Logo.jpg )
(Photo: https://mma.prnewswire.com/media/787514/Advant_Medical_Facility.jpg )

Set up in 1993 with a vision to serve the world's largest multinational corporations with medical device manufacturing, packaging solutions and dispensers, the company has over these many years exceeded their vision. Advant has seen tremendous growth since its inception under the leadership of CEO, Bob DiPetrillo and Managing Director, Debra O'Loughlin.

Domestic Growth:
In 2014, Advant purchased an injection moulding company in Inverin, Galway. This vertically integrated strategy ensures Advant as a one stop supplier serving its worldwide loyal customer base.

In 2015, Advant made additional investment in its capabilities and service offering by introducing new product development services which include 3D Printing. The ability to deliver accurate medical device prototypes portraying final product aesthetics quickly and affordably is an invaluable service.

Speaking about Advant's journey, CEO, Bob DiPetrillo said, "Advant's contract manufacturing business is focused on serving the needs of healthcare companies worldwide by providing a single-sourced solution from product conceptualisation, rapid prototyping, manufacturing and final commercial packaging."

International Growth:
Bob DiPetrillo continues, "Over the years, we grew to realise that we needed to develop operations outside of Ireland to support the worldwide demand."

In 2010 Advant launched a partnership with a manufacturing company in Reynosa, Mexico. Then in 2017, Advant invested in a standalone facility in Heredia, Costa Rica. These manufacturing facilities enable Advant to support the increased demand to supply based upon the customers' geographic location.

Debra O'Loughlin, Managing Director, reflected on the company's 25th anniversary by saying, "This has been the most interesting journey for both myself and many other long-standing employees. Our founding ethos of delivering the highest quality product and providing superior customer service remains our top priority today. From the beginning, we have carefully balanced growth, innovation, and investment."

"As we celebrate 25 years in business, a sincere thank you to the hundreds of valued customers, to our strategic partners and to our exemplary employees who have all contributed to the success of Advant Medical," concluded Mr DiPetrillo.

For further information contact Karagh Kelly, kkelly@advantmedical.com
Source: Advant Medical

Latest Press Release

The Menarini Group Announces Meropenem/vaborbactam European Marketing Authorization

- Meropenem/vaborbactam approved on 20th November 2018 by the European Commission for clinical use in adult patients with difficult-to-treat infections - The first combination of a carbapenem and a beta-lactamase inhibitor approved for clinical use in...

Merck Announces FDA Orphan Drug Designation for Bifunctional Immunotherapy M7824 in Biliary Tract Cancer

- FDA grants M7824, an investigational bifunctional immunotherapy, orphan drug designation in biliary tract cancer - First regulatory designation for M7824 following recent presentation of first clinical data in BTC - BTC is a group of rare, aggressive...

Merck in Agreement With Cyclica for AI-augmented Screening Platform to Expand Research Capabilities

- Agreement to screen discovery and early development compounds using artificial intelligence and computational biophysics - Cloud-based in silico platform that screens small molecules to determine polypharmacological profiles - Evaluation to include...

Vitality-linked Insurers to Get 100 million People 20% More Active by 2025

Building on the results of the largest behaviour change study on physical activity, Vitality and its global network of insurers have collectively committed to improving the health of millions over the next seven years. This is in line with the World...

World Congress of Cardiology Cardiovascular Health 2018 Opens in Dubai

- Professor David Wood, President of the World Heart Federation, welcomes more than 5000 cardiologists, doctors, nurses, and health and policy experts from around the world to Dubai for WCC 2018 at a time when the opportunities for a sustainable impact...

Related Topics